Search

everythinglearnresearchcommunity

for

Search:↓

The new hair loss treatment kit was safe and improved hair growth without any adverse effects.

Histone modification is key in treating chronic inflammatory skin diseases.

Tacrolimus solution is effective and well-tolerated for treating inflammatory scalp conditions.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Different cells affect hair follicle blood vessels, endothelial cells react differently to inflammation and oxidized fats, and prasugrel better protects heart vessels during a procedure than clopidogrel.

Reflectance confocal microscopy is a useful, non-invasive tool for diagnosing some skin diseases, with potential for future improvements.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

EGFR deficiency in skin causes hair follicle issues and inflammation.

Lichen planopilaris is the most common type of scarring hair loss observed, with a variety of symptoms and tissue changes.

Clinical signs don't match inflammation levels in lichen planopilaris and frontal fibrosing alopecia.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

The document concludes that stopping shaving or removing affected hair can alleviate Pseudofolliculitis barbae (PFB).

Platelet-rich plasma therapy may help treat folliculitis decalvans but benefits might not last without ongoing treatment.

Nebivolol cream may be a promising hair loss treatment by improving blood flow and nourishing hair follicles.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Stress can stop hair growth in mice, and treatments can reverse this effect.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Seborrhoeic dermatitis may cause a condition called "seborrhoeic folliculitis," leading to chronic scalp inflammation and scarring hair loss.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

The study found that the cause of alopecia areata can be identified through tissue analysis, and vertical sections are enough for diagnosis.

Cicatricial pattern hair loss is likely advanced common baldness, not a type of lichen planopilaris.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

The woman has a scalp condition causing hair loss.

Hair loss in black women needs more research, early intervention, and community education.

The document concludes that early recognition and appropriate treatment of red scalp, red ear, and red scrotum syndromes can lead to remission.

Scarring hair loss found in female pattern; biopsy needed for diagnosis.